Replimune: A Misunderstood Contender In Oncolytics
Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...
‘One of the larger mysteries I’ve ever seen’: Industrial chemical found in illicit fentanyl
The drug supply is constantly evolving, and some experts suggest that a “fourth wave” of the opioid epidemic is underway, in ...
ANI Pharmaceuticals: More Than Just A Generics Company
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
R Street Institute1d
An Ever-Changing, Increasingly Toxic Drug Supply Makes Harm Reduction Essential
Authors Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: [email protected] Harm reduction directly empowers people who use drugs to stay safer and ...
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
Current Board’s Strategic, Management, and Capital Allocation Failures Have Driven an 80% Stock Decline Over Last 22 MonthsNew Leadership is ...
Has the Bubble Burst for Viking Therapeutics Stock?
And with a growing number of companies in the GLP-1 space, investors may be losing interest in the stock. Could Viking's ...